Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 11 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Cyclophosphamide 21 Cytarabine 13 venetoclax 12 Vincristine 12 Dexamethasone 12 Methotrexate 10 Etoposide 9 Doxorubicin 9 prednylidene 8 deltacortene 8 Prednisone 8 merphos 7 dexamethasone acetate 7 dexamethasone 21-phosphate 7 auricularum 7 Calcium Dobesilate 7 fludarabine phosphate 6 pegaspargase 5 fludarabine 5 azathiopurine 5 Stem Cell Transplantation 5 Specimen Handling 5 Sirolimus 5 Mercaptopurine 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Azacitidine 5 Whole-Body Irradiation 4 Rituximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡